HKU's Virology and Microbiology Legacy: From Naming Pathogens to International Honours

Whenever researchers around the world write "HKU1" or "hongkongensis", they are citing a discovery first made at the University of Hong Kong. This is a form of authorship built not on league tables but on the letters embedded in scientific names — and behind it lies a whole institutional infrastructure stretching from the HKU-Pasteur Research Centre in 2000 to the State Key Laboratory of Emerging Infectious Diseases (SKLEID) in 2005. This article maps the research platforms underpinning HKU's flagship strength in virology, the pathogens named "HKU", and the international honours won by its leading scientists. Historically significant / award-winning scientists are named in accordance with this archive's conventions (factual passages covering 2000–12).

For the specific research contributions across successive outbreaks (1997 avian flu, 2003 SARS, 2020 COVID-19), see signature-virology-infection.md; for the overall structure of the State Key Laboratories, see institutes-and-labs.md.

---

# 1. State Key Laboratory of Emerging Infectious Diseases (SKLEID)

According to the SKLEID/Virology official page^※, the laboratory was established in October 2005 with the approval of the Ministry of Science and Technology of China. It was created by the Ministry in recognition of HKU scientists' contributions to the 2003/2004 SARS response, and is housed in the Faculty of Medicine Building at 21 Sassoon Road, Pokfulam, under the aegis of the Li Ka Shing Faculty of Medicine / School of Public Health system. It was one of the first State Key Laboratories established in Hong Kong and serves as a flagship research platform for HKU (see also institutes-and-labs.md).

According to the same official page, the laboratory's research spans emerging viruses (SARS, avian influenza, etc.), bacteria, fungi and antimicrobial resistance (AMR), adopting an integrated approach from surveillance and early warning through basic, clinical and translational research. Its publishing team includes noted scholars such as Malik Peiris, Guan Yi and Gavin J. D. Smith.

---

# 2. HKU-Pasteur Research Centre / Research Pole

# 2.1 Partnership with the Institut Pasteur

According to the HKUMed "HKU-Pasteur 20th anniversary" press release^※ and the C2i page^※, the HKU-Pasteur Research Centre is a joint laboratory between HKU and the Institut Pasteur of France, set up in 2000 with the aim of pursuing research and education of excellence in emerging viruses. According to the 20th-anniversary release, from SARS in 2003 onwards, HKU-Pasteur invested deeply in coronavirus research, consolidating the leading position of the HKU Faculty of Medicine in the field. It adopts a "One-Health" approach and has contributed to global responses to influenza, MERS, Ebola and other threats. HKU-Pasteur belongs to the Institut Pasteur International Network and benefits from the research environment of the School of Public Health.

Note: The specific founding figures of HKU-Pasteur (such as Antoine Danchin) and the 2013 organisational change (from "Research Centre" to "Research Pole", integrated into the School of Public Health) appear in some secondary reviews, but the official pages verified by this archive do not confirm these two points word-for-word. We therefore rely only on what the official pages confirm — "founded in 2000, joint with the Institut Pasteur, part of the international network" — and mark the specific founders and the 2013 restructuring as pending verification.

# 2.2 Leadership transition (factual account)

According to public sources, Professor Leo Poon succeeded Professor Malik Peiris in July 2020 as co-director of the relevant WHO-recognised centre / HKU-Pasteur. Poon studies cross-species viral transmission from animals to humans (novel influenza, coronaviruses) and has developed molecular diagnostic methods for these viruses (covering H5N1, 2009 H1N1, H7N9 and others). He has been a member of the Coronavirus Study Group of the International Committee on Taxonomy of Viruses (ICTV) since 2006 and has served on several WHO working groups on emerging viruses.

---

# 3. WHO H5 Reference Laboratory

The School of Public Health is the other pillar of HKU's virology flagship. According to public sources, HKU's Centre of Influenza Research is one of the 12 WHO H5 Reference Laboratories worldwide, responsible for providing international reference services, training, risk assessment and vaccine strain recommendations for H5 and other animal influenza viruses with zoonotic potential. This embedding in an international "surveillance–reference–early warning" network gives HKU a nodal position in global influenza/coronavirus early-warning systems. The School of Public Health is also a WHO Collaborating Centre for Infectious Disease Epidemiology and Control (since 2014); see signature-virology-infection.md §4.

---

# 4. InnoHK Virology and Immunology Centres

Within InnoHK (Health@InnoHK), two HKU-led centres continue the infectious-disease flagship tradition (see institutes-and-labs.md):

• Centre for Virology, Vaccinology and Therapeutics (CVVT): virology/vaccines/therapeutics. According to the HKU press release^※, CVVT and SKLEID jointly developed a nasal-spray H5N1 avian influenza vaccine — a continuation of the same technology platform following the nasal-spray COVID-19 vaccine (see signature-virology-infection.md §3).
• Centre for Immunology & Infection (C2i): according to the C2i page^※, its network incorporates the HKU-Pasteur Research Pole, based at the Hong Kong Science Park.

This extends HKU's infectious-disease research from campus laboratories to the government's flagship R&D platforms and the translation-to-industry end.

---

# 5. Representative Scientists and International Honours: the 2021 Future Science Prize

HKU's virology/microbiology teams have received multiple international recognitions, the most representative being the 2021 Future Science Prize in Life Science. According to the official announcement of the Future Science Prize^※ and HKU's report^※, Professor Kwok-Yung Yuen and Professor Joseph Sriyal Malik Peiris of the Li Ka Shing Faculty of Medicine received the award for their discoveries on the 2003 SARS pathogen and its zoonotic origins (which also had an impact on the fight against COVID-19). According to the announcement, the two researchers' teams treated the first patients in Hong Kong in 2003, isolated SARS-CoV-1 from clinical samples — work essential to the design of diagnostic reagents and characterisation of the disease — and Yuen's sustained research on SARS-like viruses in wild bats deepened understanding of zoonotic reservoir hosts, cross-species barriers and pathogenesis.

Note: Yuen, Peiris, Guan Yi, Leo Poon and others are all well-known scholars in the field; this archive records them by name on the basis of neutral/positive academic facts. Their research contributions, independent of any administrative positions or controversies, are recorded as matters of fact.

---

# 6. Viruses and Bacteria Named "HKU"

A number of newly discovered pathogens carry "HKU" or "hongkongensis" (of Hong Kong) directly in their scientific names — a matter of scientific fact, and a distinctive "signature" of HKU microbiology's global influence.

# 6.1 Human coronavirus HKU1 (2005)

After SARS in 2003, HKU's microbiology team stepped up screening of respiratory patients for unknown pathogens — and found a novel human coronavirus.

• According to the original paper published in the Journal of Virology (January 2005)^※, the virus was identified by Patrick C. Y. Woo, Susanna K. P. Lau and colleagues of the Department of Microbiology, in a paper titled Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia.
• According to the same paper and the Wikipedia summary^※, the virus was first detected in a 71-year-old man with pneumonia who had just returned to Hong Kong from Shenzhen; it was named Coronavirus HKU1, with "HKU" taken from the University of Hong Kong.
• In a retrospective analysis reported in the paper^※, the team re-examined "SARS-negative" nasopharyngeal aspirate samples collected during SARS 2003 and detected HKU1 RNA in a sample from a 35-year-old woman with pneumonia — evidence that the virus had already been circulating in humans, but had simply never been identified until this study.

# 6.2 Bat coronaviruses HKU2–HKU13: an entire "HKU-numbered" family

SARS 2003 propelled bats to the front of research on viral reservoir hosts. The HKU team subsequently discovered and named a series of novel coronaviruses in bats and other wildlife. According to the Wikipedia biography of Yuen Kwok-yung^※, besides the human coronavirus HKU1, his team identified bat coronaviruses HKU2 through HKU13 among other novel viruses, as well as multiple new bacteria named after Hong Kong or China.

Background statement (based on public compilations): Systematically numbering discovered viruses as "HKU + serial number" was the result of years of systematic sampling, sequencing and naming by the HKU team. The institutional basis for this work is precisely the SKLEID described in §1. The vast majority of these "HKU-numbered" viruses are of animal origin and do not necessarily infect humans, but they constitute an important reference bank for understanding coronavirus evolution and cross-species transmission.

# 6.3 Laribacter hongkongensis (2001)

The HKU team's "Hong Kong imprint" extends beyond viruses into the bacterial world. According to research on its eco-epidemiology in the Journal of Clinical Microbiology^※ and a multi-locus sequence typing study (PMC)^※, Laribacter hongkongensis was first isolated in 2001 from the blood and empyema specimen of a patient with alcoholic cirrhosis. It is a Gram-negative, facultatively anaerobic, seagull-shaped bacillus, subsequently found to be associated with freshwater-fish-related gastroenteritis and traveller's diarrhoea. In territory-wide surveillance, the bacterium was isolated mainly from freshwater fish (with varying detection rates in species such as grass carp, bighead carp and mud carp), and detection rates were higher in spring and summer than in autumn and winter. Its species epithet hongkongensis literally means "of Hong Kong" — writing the place of discovery permanently into the scientific name of a new genus and species.

# 6.4 Why this string of names matters

These names merit a section of their own because they crystallise HKU microbiology's workflow of "systematic sampling — rapid sequencing — standardised naming" into proper nouns that can be cited repeatedly across the global literature.

---

# 7. Summary and items pending verification

• Securely sourced: SKLEID (2005, established in recognition of SARS contributions), HKU-Pasteur (2000, joint with the Institut Pasteur, One-Health), WHO H5 Reference Laboratory, InnoHK CVVT/C2i, 2021 Future Science Prize, HKU1/HKU2–13/Laribacter hongkongensis — all supported by official or academic sources.
• Pending verification: HKU-Pasteur's founders by name (Antoine Danchin et al.) and the 2013 reorganisation from "Research Centre" to "Research Pole" — not confirmed word-for-word on official pages; the individual first-report years and hosts of each of HKU2–HKU13 — Mr. Yuen's biography gives only a series-level overview and each item requires checking the original papers and virus databases; the complete list of "HKU-series" pathogens — requires checking SKLEID and the teams' publication lists; the latest taxonomic classifications of the viral/bacterial names — refer to official databases.
• Cross-references: for the specific research contributions and timelines across successive outbreaks (1997/2003/2020), see signature-virology-infection.md; for the overall structure of the State Key Laboratories and InnoHK, see institutes-and-labs.md; for the Faculty of Medicine and Queen Mary Hospital, see ../11-medical-hospital/; for the place of the virology tradition within HKU's overall research output (RAE/RGC/Nature Index), see achievements.md.

---